 |
| ADVERTISE HERE |
Your Source for Pharmaceutical Industry Intelligence
Ultimate Plancompare plans | |
   
| |
| $475 / One Month | $1,895 / One Year |
 | |
| Need an invoice? Group rate? Contact admin@DrugPatentWatch.com | |
Search for Tradename: NEXIUM IV
Summary for Tradename: NEXIUM IV
|
|
Latest news for NEXIUMOn Your Side: Are Prescription Drug Prices Killing You? (WLTX-TV Columbia)8 February 2010, 11:43 pm AstraZeneca gets OK for expanded Crestor use (USA Today)8 February 2010, 8:07 pm AstraZeneca gets OK for expanded Crestor use (Bay News 9 Tampa Bay)8 February 2010, 7:12 pm AstraZeneca gets OK for expanded Crestor use (San Francisco Chronicle)8 February 2010, 6:30 pm Dr. Gott 2/06/2010 (The Scranton Times-Tribune)6 February 2010, 9:42 am Back at work - for a while today (Northeast Mississippi Daily Journal)4 February 2010, 11:40 am AstraZeneca facing 26,000 suits over Seroquel (The News Journal)4 February 2010, 7:49 am Cephalon buys Swiss generic maker Mepha (The News Journal)4 February 2010, 7:47 am Back to the news: McCoy, Neilson (Northeast Mississippi Daily Journal)3 February 2010, 2:54 pm Courtesy of Yahoo News |
Glossary
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | NEXIUM IV | esomeprazole sodium | 021689 | Mar 31, 2005 | RX | Yes | 5,877,192*PED | Y | Nov 27, 2014 | |||
| Astrazeneca | NEXIUM IV | esomeprazole sodium | 021689 | Mar 31, 2005 | RX | Yes | 6,143,771 | Y | May 27, 2014 |
This preview shows a limited data set. Complete access is available with a Subscription Plan
Paragraph IV activity for: NEXIUM IV
| Drugname | Dosage | Strength | RLD | Submissiondate |
| esomeprazole sodium | For Injection | 20 mg/vial and 40 mg/vial | Nexium IV | 11/23/2009 |
<- Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.
Follow DrugPatentWatch on Twitter![[del.icio.us]](/inc/bookmarkify/delicious.png)
![[Digg]](/inc/bookmarkify/digg.png)
![[LinkedIn]](/inc/bookmarkify/linkedin.png)
![[StumbleUpon]](/inc/bookmarkify/stumbleupon.png)
![[Technorati]](/inc/bookmarkify/technorati.png)
![[Twitter]](/inc/bookmarkify/twitter.png)
![[Email]](/inc/bookmarkify/email.png)
